Table 2.
Number of Normal and Endometriosis Patients According to the Intensity of IL-1RII Cellular Immunostaining in the Stroma, and in the Glands and Surface Epithelium
| Stroma intensity of staining | P value* | Glands and surface epithelium intensity of staining | P value* | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 0 | 1 | 2 | 3 | |||
| Controls | 3 | 19 | 12 | 4 | 2 | 13 | 17 | 7 | ||
| Endometriosis (total) | 5 | 25 | 22 | 0 | 0.1120 | 4 | 21 | 26 | 1 | 0.0660 |
| Stage I | 1 | 9 | 13 | 0 | 0.1750 | 3 | 7 | 13 | 0 | 0.1030 |
| Stage II | 3 | 10 | 3 | 0 | 0.3240 | 0 | 10 | 5 | 1 | 0.2580 |
| Stage III–IV | 1 | 6 | 6 | 0 | 0.7120 | 1 | 4 | 8 | 0 | 0.3680 |
| Fertile | 1 | 10 | 13 | 0 | 0.1910 | 1 | 9 | 14 | 0 | 0.1280 |
| Infertile | 11 | 15 | 9 | 0 | 0.3350 | 3 | 12 | 12 | 1 | 0.3010 |
| Controls | ||||||||||
| Proliferative phase | 2 | 15 | 0 | 1 | 2 | 9 | 6 | 1 | ||
| Secretory phase | 1 | 4 | 12 | 3 | 2 ×10−5† | 0 | 4 | 11 | 6 | 0.0310† |
| Endometriosis | ||||||||||
| Proliferative phase | 4 | 14 | 3 | 0 | 3 | 14 | 4 | 0 | ||
| Secretory phase | 1 | 11 | 19 | 0 | 0.0011† | 1 | 7 | 22 | 1 | 0.0004 |
| Proliferative phase | ||||||||||
| Control | 2 | 15 | 0 | 1 | 2 | 9 | 6 | 1 | ||
| Endometriosis | 4 | 14 | 3 | 0 | 0.2430 | 3 | 14 | 4 | 0 | 0.6060 |
| Secretory phase | ||||||||||
| Control | 1 | 4 | 12 | 3 | 0 | 4 | 11 | 6 | ||
| Endometriosis | 1 | 11 | 19 | 0 | 0.0910 | 1 | 7 | 22 | 1 | 0.0530 |
*Comparison with controls, P values corrected by the Bonferroni procedure.
†Comparison of the proliferative phase with the secretory phase.